Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image
"Oz should invite LaMattina back on his show.  Since LaMattina treats all concerns respectfully, Oz needn’t worry about feeling devalued or distrusted."  (Barron's, 5 May 2014)“This is an honest book by an insider who believes in the basic good that the industry does.”  (The Quarterly Review of Biology, 1 September 2013)“Summing Up:  Recommended.  General audiences.”  (Choice, 1 September 2013)“For those more loosely associated or aspiring to work with in it, I particularly recommend this book as a balanced and informative read on the pressures the industry faces. It should also provide the basis for more reasoned argument and forewarn anyone else potentially ambushed by a TV show.”  (ChemMedChem, 19 July 2013)“That said, the suggestions made by LaMattina for improvements in productivity and transparency are timely, and the book makes interesting if unexciting reading.”  (Chemistry & Industry, 1 June 2013)“John LaMattina (ex-head of Pfizer's global R&D) has a new book out about the industry, called Devalued and Distrusted.  He tellsPharmalotthat he got the idea to write a sequel to his earlier book, Drug Truths, when he appeared on the "Dr. Oz" show.”  (In The Pipeline, 1 December 2012)